MicroRNA-15b Modulates Cellular ATP Levels and Degenerates Mitochondria Via Arl2 in Neonatal Rat Cardiac Myocytes

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2009 Dec 17

PMID 20007690

Citations 73

Authors

Hitoo Nishi

Koh Ono

Yoshitaka Iwanaga

Takahiro Horie

Kazuya Nagao

Genzou Takemura

Minako Kinoshita

Yasuhide Kuwabara

Rieko Takanabe Mori

Koji Hasegawa

Toru Kita

Takeshi Kimura

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs or miRs) are small, non-coding RNAs that modulate mRNA stability and post-transcriptional translation. A growing body of evidence indicates that specific miRNAs can affect the cellular function of cardiomyocytes. In the present study, miRNAs that are highly expressed in the heart were overexpressed in neonatal rat ventricular myocytes, and cellular ATP levels were assessed. As a result, miR-15b, -16, -195, and -424, which have the same seed sequence, the most critical determinant of miRNA targeting, decreased cellular ATP levels. These results suggest that these miRNAs could specifically down-regulate the same target genes and consequently decrease cellular ATP levels. Through a bioinformatics approach, ADP-ribosylation factor-like 2 (Arl2) was identified as a potential target of miR-15b. It has already been shown that Arl2 localizes to adenine nucleotide transporter 1, the exchanger of ADP/ATP in mitochondria. Overexpression of miR-15b, -16, -195, and -424 suppressed the activity of a luciferase reporter construct fused with the 3'-untranslated region of Arl2. In addition, miR-15b overexpression decreased Arl2 mRNA and protein expression levels. The effects of Arl2 siRNA on cellular ATP levels were the same as those of miR-15b, and the expression of Arl2 could restore ATP levels reduced by miR-15b. A loss-of-function study of miR-15b resulted in increased Arl2 protein and cellular ATP levels. Electron microscopic analysis revealed that mitochondria became degenerated in cardiomyocytes that had been transduced with miR-15b and Arl2 siRNA. The present results suggest that miR-15b may decrease mitochondrial integrity by targeting Arl2 in the heart.

Citing Articles

Extracellular vesicle-mediated bidirectional communication between the liver and other organs: mechanistic exploration and prospects for clinical applications.

Mo W, Peng Y, Zheng Y, Zhao S, Deng L, Fan X J Nanobiotechnology. 2025; 23(1):190.

PMID: 40055724 PMC: 11889855. DOI: 10.1186/s12951-025-03259-4.

Biological Function Analysis of MicroRNAs and Proteins in the Cerebrospinal Fluid of Patients with Parkinson's Disease.

Hwang J, Kim S, George N, Kwon M, Jang Y, Lee S Int J Mol Sci. 2025; 25(24.

PMID: 39769025 PMC: 11678473. DOI: 10.3390/ijms252413260.

miR-29a activates expression of α-cardiac myosin heavy chain via β1 thyroid hormone receptor in neonatal rats.

Wang C, He R, Liu X, Li J, Pan R Arch Med Sci. 2024; 20(2):641-654.

PMID: 38757019 PMC: 11094831. DOI: 10.5114/aoms.2019.91495.

Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients.

Moatar A, Chis A, Romanescu M, Ciordas P, Nitusca D, Marian C Sci Rep. 2023; 13(1):13806.

PMID: 37612439 PMC: 10447562. DOI: 10.1038/s41598-023-40754-w.

The Arf family GTPases: Regulation of vesicle biogenesis and beyond.

Li F, Guan K Bioessays. 2023; 45(6):e2200214.

PMID: 36998106 PMC: 10282109. DOI: 10.1002/bies.202200214.

References

Hasegawa K, MEYERS M, Kitsis R . Transcriptional coactivator p300 stimulates cell type-specific gene expression in cardiac myocytes. J Biol Chem. 1997; 272(32):20049-54. DOI: 10.1074/jbc.272.32.20049. View

Van Rooij E, Sutherland L, Liu N, Williams A, McAnally J, Gerard R . A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103(48):18255-60. PMC: 1838739. DOI: 10.1073/pnas.0608791103. View

Murdock D, Boone B, Esposito L, Wallace D . Up-regulation of nuclear and mitochondrial genes in the skeletal muscle of mice lacking the heart/muscle isoform of the adenine nucleotide translocator. J Biol Chem. 1999; 274(20):14429-33. DOI: 10.1074/jbc.274.20.14429. View

Rupp H, Elimban V, Dhalla N . Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J. 1992; 6(6):2349-53. DOI: 10.1096/fasebj.6.6.1531968. View

Levy S, Chen Y, Graham B, Wallace D . Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. Gene. 2000; 254(1-2):57-66. DOI: 10.1016/s0378-1119(00)00252-3. View

Dolce V, Scarcia P, Iacopetta D, Palmieri F . A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution. FEBS Lett. 2005; 579(3):633-7. DOI: 10.1016/j.febslet.2004.12.034. View

Schaper J, FROEDE R, Hein S, Buck A, Hashizume H, Speiser B . Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991; 83(2):504-14. DOI: 10.1161/01.cir.83.2.504. View

Dorner A, Olesch M, Giessen S, Pauschinger M, Schultheiss H . Transcription of the adenine nucleotide translocase isoforms in various types of tissues in the rat. Biochim Biophys Acta. 1999; 1417(1):16-24. DOI: 10.1016/s0005-2736(98)00245-4. View

Mercadier J, Lompre A, Wisnewsky C, Samuel J, Bercovici J, Swynghedauw B . Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ Res. 1981; 49(2):525-32. DOI: 10.1161/01.res.49.2.525. View

10.

Dorner A, Schultheiss H . Adenine nucleotide translocase in the focus of cardiovascular diseases. Trends Cardiovasc Med. 2007; 17(8):284-90. DOI: 10.1016/j.tcm.2007.10.001. View

11.

Sharer J, Shern J, Van Valkenburgh H, Wallace D, Kahn R . ARL2 and BART enter mitochondria and bind the adenine nucleotide transporter. Mol Biol Cell. 2002; 13(1):71-83. PMC: 65073. DOI: 10.1091/mbc.01-05-0245. View

12.

Cimmino A, Calin G, Fabbri M, Iorio M, Ferracin M, Shimizu M . miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 102(39):13944-9. PMC: 1236577. DOI: 10.1073/pnas.0506654102. View

13.

Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A . Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol. 2003; 23(10):3593-606. PMC: 154243. DOI: 10.1128/MCB.23.10.3593-3606.2003. View

14.

Chen X, Van Valkenburgh C, Fang H, Green N . Signal peptides having standard and nonstandard cleavage sites can be processed by Imp1p of the mitochondrial inner membrane protease. J Biol Chem. 1999; 274(53):37750-4. DOI: 10.1074/jbc.274.53.37750. View

15.

Barth E, Stammler G, Speiser B, Schaper J . Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J Mol Cell Cardiol. 1992; 24(7):669-81. DOI: 10.1016/0022-2828(92)93381-s. View

16.

Stepien G, Torroni A, Chung A, Hodge J, Wallace D . Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J Biol Chem. 1992; 267(21):14592-7. View

17.

Das A, Harris D . Regulation of the mitochondrial ATP synthase in intact rat cardiomyocytes. Biochem J. 1990; 266(2):355-61. PMC: 1131139. DOI: 10.1042/bj2660355. View

18.

Soubannier V, McBride H . Positioning mitochondrial plasticity within cellular signaling cascades. Biochim Biophys Acta. 2008; 1793(1):154-70. DOI: 10.1016/j.bbamcr.2008.07.008. View

19.

Bhamidipati A, Lewis S, Cowan N . ADP ribosylation factor-like protein 2 (Arl2) regulates the interaction of tubulin-folding cofactor D with native tubulin. J Cell Biol. 2000; 149(5):1087-96. PMC: 2174823. DOI: 10.1083/jcb.149.5.1087. View

20.

Johnson D, Harris R, French S, Blair P, You J, Bemis K . Tissue heterogeneity of the mammalian mitochondrial proteome. Am J Physiol Cell Physiol. 2006; 292(2):C689-97. DOI: 10.1152/ajpcell.00108.2006. View